 | • レポートコード：QY2108PAL8810 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける診断用放射性医薬品の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、診断用放射性医薬品の種類別市場規模（テクネチウム99、フッ素18、その他）、用途別市場規模（腫瘍、心臓病、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の診断用放射性医薬品市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における診断用放射性医薬品の種類別市場規模（2016年-2027年）：テクネチウム99、フッ素18、その他 ・世界における診断用放射性医薬品の用途別市場規模（2016年-2027年）：腫瘍、心臓病、その他 ・診断用放射性医薬品の中国市場分析 - 診断用放射性医薬品の中国市場規模（2016年-2027年） - 中国における診断用放射性医薬品の主要プレイヤー別市場シェア - 中国における診断用放射性医薬品の種類別市場規模：テクネチウム99、フッ素18、その他 - 中国における診断用放射性医薬品の用途別市場規模：腫瘍、心臓病、その他 ・診断用放射性医薬品の北米市場（2016年-2027年） ・診断用放射性医薬品のヨーロッパ市場（2016年-2027年） ・診断用放射性医薬品のアジア太平洋市場（2016年-2027年） ・診断用放射性医薬品の中南米市場（2016年-2027年） ・診断用放射性医薬品の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Cardinal Health、GE Healthcare、Curium Pharma、Jubilant Pharma、Bracco Imaging、Advanced Accelerator Applications、SIEMENS、China Isotope & Radiation、Dongcheng Pharmaceutical Group、Lantheus、Eli Lilly ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
North America is the world’s major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Market Analysis and Insights: Global and China Diagnostic Radiopharmaceuticals Market
This report focuses on global and China Diagnostic Radiopharmaceuticals market.
In 2020, the global Diagnostic Radiopharmaceuticals market size was US$ 4102 million and it is expected to reach US$ 6544 million by the end of 2027, with a CAGR of 6.9% during 2021-2027. In China the Diagnostic Radiopharmaceuticals market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Diagnostic Radiopharmaceuticals Scope and Market Size
Diagnostic Radiopharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Diagnostic Radiopharmaceuticals market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Technetium 99
Fluorine 18
Other
Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.
Segment by Application
Oncology
Cardiology
Other
Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
1 Study Coverage
1.1 Diagnostic Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diagnostic Radiopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Diagnostic Radiopharmaceuticals Revenue 2016-2027
2.1.2 Global Diagnostic Radiopharmaceuticals Sales 2016-2027
2.2 Global Diagnostic Radiopharmaceuticals, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Diagnostic Radiopharmaceuticals Historical Market Size by Region (2016-2021)
2.3.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.4.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
3 Global Diagnostic Radiopharmaceuticals Competitor Landscape by Players
3.1 Global Top Diagnostic Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Diagnostic Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Key Diagnostic Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2016-2021)
3.2.3 Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Diagnostic Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals Revenue in 2020
3.2.6 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Diagnostic Radiopharmaceuticals Price by Manufacturers
3.4 Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Diagnostic Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diagnostic Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Diagnostic Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Diagnostic Radiopharmaceuticals Market Size by Type (2016-2021)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2016-2021)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2016-2021)
4.1.3 Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2022-2027)
4.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Diagnostic Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Diagnostic Radiopharmaceuticals Market Size by Application (2016-2021)
5.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2016-2021)
5.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2016-2021)
5.1.3 Diagnostic Radiopharmaceuticals Price by Application (2016-2021)
5.2 Diagnostic Radiopharmaceuticals Market Size Forecast by Application (2022-2027)
5.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Diagnostic Radiopharmaceuticals Market Size YoY Growth 2016-2027
6.1.1 China Diagnostic Radiopharmaceuticals Sales YoY Growth 2016-2027
6.1.2 China Diagnostic Radiopharmaceuticals Revenue YoY Growth 2016-2027
6.1.3 China Diagnostic Radiopharmaceuticals Market Share in Global Market 2016-2027
6.2 China Diagnostic Radiopharmaceuticals Market Size by Players (International and Local Players)
6.2.1 China Top Diagnostic Radiopharmaceuticals Players by Sales (2016-2021)
6.2.2 China Top Diagnostic Radiopharmaceuticals Players by Revenue (2016-2021)
6.3 China Diagnostic Radiopharmaceuticals Historic Market Review by Type (2016-2021)
6.3.1 China Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
6.3.2 China Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
6.3.3 China Diagnostic Radiopharmaceuticals Price by Type (2016-2021)
6.4 China Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Diagnostic Radiopharmaceuticals Sales Forecast by Type (2022-2027)
6.4.2 China Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
6.4.3 China Diagnostic Radiopharmaceuticals Price Forecast by Type (2022-2027)
6.5 China Diagnostic Radiopharmaceuticals Historic Market Review by Application (2016-2021)
6.5.1 China Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
6.5.2 China Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
6.5.3 China Diagnostic Radiopharmaceuticals Price by Application (2016-2021)
6.6 China Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Diagnostic Radiopharmaceuticals Sales Forecast by Application (2022-2027)
6.6.2 China Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
6.6.3 China Diagnostic Radiopharmaceuticals Price Forecast by Application (2022-2027)
7 North America
7.1 North America Diagnostic Radiopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
7.2.2 North America Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Diagnostic Radiopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2016-2021)
8.2.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Diagnostic Radiopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
9.2.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Diagnostic Radiopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
10.2.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
11.2.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Cardinal Health
12.1.1 Cardinal Health Corporation Information
12.1.2 Cardinal Health Description and Business Overview
12.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
12.1.5 Cardinal Health Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Description and Business Overview
12.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Curium Pharma
12.3.1 Curium Pharma Corporation Information
12.3.2 Curium Pharma Description and Business Overview
12.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Products Offered
12.3.5 Curium Pharma Recent Development
12.4 Jubilant Pharma
12.4.1 Jubilant Pharma Corporation Information
12.4.2 Jubilant Pharma Description and Business Overview
12.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
12.4.5 Jubilant Pharma Recent Development
12.5 Bracco Imaging
12.5.1 Bracco Imaging Corporation Information
12.5.2 Bracco Imaging Description and Business Overview
12.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
12.5.5 Bracco Imaging Recent Development
12.6 Advanced Accelerator Applications
12.6.1 Advanced Accelerator Applications Corporation Information
12.6.2 Advanced Accelerator Applications Description and Business Overview
12.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Products Offered
12.6.5 Advanced Accelerator Applications Recent Development
12.7 SIEMENS
12.7.1 SIEMENS Corporation Information
12.7.2 SIEMENS Description and Business Overview
12.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 SIEMENS Diagnostic Radiopharmaceuticals Products Offered
12.7.5 SIEMENS Recent Development
12.8 China Isotope & Radiation
12.8.1 China Isotope & Radiation Corporation Information
12.8.2 China Isotope & Radiation Description and Business Overview
12.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
12.8.5 China Isotope & Radiation Recent Development
12.9 Dongcheng Pharmaceutical Group
12.9.1 Dongcheng Pharmaceutical Group Corporation Information
12.9.2 Dongcheng Pharmaceutical Group Description and Business Overview
12.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Products Offered
12.9.5 Dongcheng Pharmaceutical Group Recent Development
12.10 Lantheus
12.10.1 Lantheus Corporation Information
12.10.2 Lantheus Description and Business Overview
12.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lantheus Diagnostic Radiopharmaceuticals Products Offered
12.10.5 Lantheus Recent Development
12.11 Cardinal Health
12.11.1 Cardinal Health Corporation Information
12.11.2 Cardinal Health Description and Business Overview
12.11.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
12.11.5 Cardinal Health Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Diagnostic Radiopharmaceuticals Industry Trends
13.2 Diagnostic Radiopharmaceuticals Market Drivers
13.3 Diagnostic Radiopharmaceuticals Market Challenges
13.4 Diagnostic Radiopharmaceuticals Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diagnostic Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Technetium 99
Table 3. Major Manufacturers of Fluorine 18
Table 4. Major Manufacturers of Other
Table 5. Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Diagnostic Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Diagnostic Radiopharmaceuticals Sales by Regions (2016-2021) & (K Units)
Table 8. Global Diagnostic Radiopharmaceuticals Sales Market Share by Regions (2016-2021)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Diagnostic Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Diagnostic Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 17. Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 19. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2020)
Table 21. Key Manufacturers Diagnostic Radiopharmaceuticals Price (2016-2021) (US$/Unit)
Table 22. Diagnostic Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Diagnostic Radiopharmaceuticals Product Type
Table 24. Date of International Manufacturers Enter into Diagnostic Radiopharmaceuticals Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) (K Units)
Table 27. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 28. Global Diagnostic Radiopharmaceuticals Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 30. Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Diagnostic Radiopharmaceuticals Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Diagnostic Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) (K Units)
Table 37. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 38. Global Diagnostic Radiopharmaceuticals Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 40. Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Diagnostic Radiopharmaceuticals Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Diagnostic Radiopharmaceuticals Sales (K Units) of Key Companies (2016-2021)
Table 47. China Diagnostic Radiopharmaceuticals Sales Share by Company (2016-2021)
Table 48. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 49. China Diagnostic Radiopharmaceuticals Revenue Share by Company (2016-2021)
Table 50. China Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 51. China Diagnostic Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 52. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Diagnostic Radiopharmaceuticals Price (US$/Unit) by Type (2016-2021)
Table 54. China Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2022-2027)
Table 55. China Diagnostic Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 56. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Diagnostic Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 58. China Diagnostic Radiopharmaceuticals Price (US$/Unit) by Type (2022-2027)
Table 59. China Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 60. China Diagnostic Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 61. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Diagnostic Radiopharmaceuticals Price (US$/Unit) by Application (2016-2021)
Table 63. China Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2022-2027)
Table 64. China Diagnostic Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 65. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Diagnostic Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 67. China Diagnostic Radiopharmaceuticals Price (US$/Unit) by Application (2022-2027)
Table 68. North America Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 69. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 70. North America Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 76. Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 77. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 78. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 80. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 88. Cardinal Health Corporation Information
Table 89. Cardinal Health Description and Business Overview
Table 90. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 92. Cardinal Health Recent Development
Table 93. GE Healthcare Corporation Information
Table 94. GE Healthcare Description and Business Overview
Table 95. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. GE Healthcare Product
Table 97. GE Healthcare Recent Development
Table 98. Curium Pharma Corporation Information
Table 99. Curium Pharma Description and Business Overview
Table 100. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Curium Pharma Product
Table 102. Curium Pharma Recent Development
Table 103. Jubilant Pharma Corporation Information
Table 104. Jubilant Pharma Description and Business Overview
Table 105. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Jubilant Pharma Product
Table 107. Jubilant Pharma Recent Development
Table 108. Bracco Imaging Corporation Information
Table 109. Bracco Imaging Description and Business Overview
Table 110. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Bracco Imaging Product
Table 112. Bracco Imaging Recent Development
Table 113. Advanced Accelerator Applications Corporation Information
Table 114. Advanced Accelerator Applications Description and Business Overview
Table 115. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Advanced Accelerator Applications Product
Table 117. Advanced Accelerator Applications Recent Development
Table 118. SIEMENS Corporation Information
Table 119. SIEMENS Description and Business Overview
Table 120. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. SIEMENS Product
Table 122. SIEMENS Recent Development
Table 123. China Isotope & Radiation Corporation Information
Table 124. China Isotope & Radiation Description and Business Overview
Table 125. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. China Isotope & Radiation Product
Table 127. China Isotope & Radiation Recent Development
Table 128. Dongcheng Pharmaceutical Group Corporation Information
Table 129. Dongcheng Pharmaceutical Group Description and Business Overview
Table 130. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Dongcheng Pharmaceutical Group Product
Table 132. Dongcheng Pharmaceutical Group Recent Development
Table 133. Lantheus Corporation Information
Table 134. Lantheus Description and Business Overview
Table 135. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Lantheus Product
Table 137. Lantheus Recent Development
Table 138. Eli Lilly Corporation Information
Table 139. Eli Lilly Description and Business Overview
Table 140. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Eli Lilly Product
Table 142. Eli Lilly Recent Development
Table 143. Diagnostic Radiopharmaceuticals Market Trends
Table 144. Diagnostic Radiopharmaceuticals Market Drivers
Table 145. Diagnostic Radiopharmaceuticals Market Challenges
Table 146. Diagnostic Radiopharmaceuticals Market Restraints
Table 147. Diagnostic Radiopharmaceuticals Customers List
Table 148. Diagnostic Radiopharmaceuticals Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Product Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020 & 2027
Figure 3. Technetium 99 Product Picture
Figure 4. Fluorine 18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020 & 2027
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 11. Global Diagnostic Radiopharmaceuticals Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Diagnostic Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 13. Global Diagnostic Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 14. Global Diagnostic Radiopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 16. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 17. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 18. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 19. Global Diagnostic Radiopharmaceuticals Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Diagnostic Radiopharmaceuticals Revenue in 2020
Figure 21. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 23. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type in 2020
Figure 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 27. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 28. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2020
Figure 30. China Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Diagnostic Radiopharmaceuticals Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue in Diagnostic Radiopharmaceuticals in 2020
Figure 34. China Diagnostic Radiopharmaceuticals Revenue Share by Type (2016-2021)
Figure 35. China Diagnostic Radiopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Diagnostic Radiopharmaceuticals Revenue Share by Application (2016-2021)
Figure 37. China Diagnostic Radiopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 41. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 42. U.S. Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 49. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 50. Germany Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 63. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 64. China Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 83. Philippines Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 85. Vietnam Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 89. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 90. Mexico Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 100. Turkey Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Diagnostic Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 105. UAE Diagnostic Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Diagnostic Radiopharmaceuticals Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
核医学・放射性医薬品の世界及び中国市場 Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceuti…- 核医学/放射性医薬品の世界市場 2020年 Market Overview The Nuclear Medicine/Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 放射性医薬品の世界市場 2020年 Market Overview The Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の診断用柔軟性カテーテル市場インサイト・予測（～2027年） Flexible Diagnostic Catheters are flexible tubes designed to deliver radiopaque media, guidewires, and therapeutic agents to selected sites in the vascular system. Market Analysis and Insights: Global Flexible Diagnostic Catheter Market The global Flexible Diagnostic Catheter market is valued at US$…
- 世界の診断用マイクロカテーテル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Diagnostic Microcatheters Market The global Diagnostic Microcatheters market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Diagnostic Microcatheters Scope and S…